Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Post-discharge surgical site surveillance - where to from here?
Hall L, Halton K, Bailey EJ, Page K, Whitby M, Paterson DL, Graves N.
J Hosp Infect. 2013 Jun 6. doi:pii: S0195-6701(13)00150-3. 10.1016/j.jhin.2013.02.021. [Epub ahead of print] No abstract available.
Related citations
Pharmacokinetics of meropenem and piperacillin in critically ill patients with indwelling surgical drains.
Adnan S, Li JX, Wallis SC, Rudd M, Jarrett P, Paterson DL, Lipman J, Udy AA, Roberts JA.
Int J Antimicrob Agents. 2013 Apr 13. doi:pii: S0924-8579(13)00084-8. 10.1016/j.ijantimicag.2013.02.023. [Epub ahead of print]
Reply to "Vancomycin-induced nephrotoxicity".
van Hal SJ, Paterson DL, Lodise TP.
Antimicrob Agents Chemother. 2013 May;57(5):2436. doi: 10.1128/AAC.00320-13. No abstract available.
Listeriosis in patients receiving biologic therapies.
Bodro M, Paterson DL.
Eur J Clin Microbiol Infect Dis. 2013 Apr 9. [Epub ahead of print]
Reply to Soman et al.
Dulhunty JM, Roberts JA, Davis JS, Webb SA, Bellomo R, Gomersall C, Shirwadkar C, Eastwood GM, Myburgh J, Paterson DL, Lipman J.
Clin Infect Dis. 2013 Apr 15. [Epub ahead of print] No abstract available.
Infectious Complications Following Transrectal Ultrasound-Guided Prostate Biopsy: New Challenges in the Era of Multidrug-Resistant Escherichia coli.
Williamson DA, Barrett LK, Rogers BA, Freeman JT, Hadway P, Paterson DL.
Clin Infect Dis. 2013 Apr 12. [Epub ahead of print]
Determining research priorities for clinician-initiated trials in infectious diseases.
Paterson DL; Steering Group of the Australasian Society for Infectious Diseases Clinical Research Network.
Med J Aust. 2013 Mar 18;198(5):270-2.
Gram-negative resistance: can we combat the coming of a new "Red Plague"?
Looke DF, Gottlieb T, Jones CA, Paterson DL.
Med J Aust. 2013 Mar 18;198(5):243-4. No abstract available.
Prevalence of NDM-1 carbapenemase in patients with diarrhoea in Pakistan and evaluation of two chromogenic culture media.
Day KM, Salman M, Kazi B, Sidjabat HE, Silvey A, Lanyon CV, Cummings SP, Ali MN, Raza MW, Paterson DL, Perry JD.
J Appl Microbiol. 2013 Jun;114(6):1810-6. doi: 10.1111/jam.12171. Epub 2013 Mar 6.
Has the time come for routine trimethoprim-sulfamethoxazole prophylaxis in patients taking biologic therapies?
Clin Infect Dis. 2013 Jun;56(11):1621-8. doi: 10.1093/cid/cit071. Epub 2013 Feb 7.
Treatment options for New Delhi metallo-beta-lactamase-harboring enterobacteriaceae.
Rogers BA, Sidjabat HE, Silvey A, Anderson TL, Perera S, Li J, Paterson DL.
Microb Drug Resist. 2013 Apr;19(2):100-3. doi: 10.1089/mdr.2012.0063. Epub 2013 Jan 18.
Emergence of bla(OXA-181)-carrying ColE plasmid in Klebsiella pneumoniae in Australia.
Sidjabat HE, Kennedy K, Silvey A, Collignon P, Paterson DL.
Int J Antimicrob Agents. 2013 Mar;41(3):294-6. doi: 10.1016/j.ijantimicag.2012.11.003. Epub 2013 Jan 10. No abstract available.
Monitoring the global in vitro activity of ertapenem against Escherichia coli from intra-abdominal infections: SMART 2002-2010.
Hawser SP, Badal RE, Bouchillon SK, Hoban DJ, Biedenbach DJ, Cantón R, Paterson DL.
Int J Antimicrob Agents. 2013 Mar;41(3):224-8. doi: 10.1016/j.ijantimicag.2012.10.014. Epub 2013 Jan 8.
Predominance of VREfm ST203 subgroup in Queensland.
Kamolvit W, Sidjabat HE, Nimmo GR, Anuj SN, Bergh H, Richardson LJ, Paterson DL.
Pathology. 2013 Jan;45(1):99. doi: 10.1097/PAT.0b013e32835b68d2. No abstract available.
Prevalence and molecular characterization of Enterobacteriaceae producing NDM-1 carbapenemase at a military hospital in Pakistan and evaluation of two chromogenic media.
Day KM, Ali S, Mirza IA, Sidjabat HE, Silvey A, Lanyon CV, Cummings SP, Abbasi SA, Raza MW, Paterson DL, Perry JD.
Diagn Microbiol Infect Dis. 2013 Feb;75(2):187-91. doi: 10.1016/j.diagmicrobio.2012.11.006. Epub 2012 Dec 14.
Vancomycin therapeutics and monitoring: a contemporary approach.
Avent ML, Vaska VL, Rogers BA, Cheng AC, van Hal SJ, Holmes NE, Howden BP, Paterson DL.
Intern Med J. 2013 Feb;43(2):110-9. doi: 10.1111/imj.12036.
Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter.
Antimicrob Agents Chemother. 2013 Feb;57(2):734-44. doi: 10.1128/AAC.01568-12. Epub 2012 Nov 19.
Community-associated extended-spectrum β-lactamase-producing Escherichia coli infection in the United States.
Doi Y, Park YS, Rivera JI, Adams-Haduch JM, Hingwe A, Sordillo EM, Lewis JS 2nd, Howard WJ, Johnson LE, Polsky B, Jorgensen JH, Richter SS, Shutt KA, Paterson DL.
Clin Infect Dis. 2013 Mar;56(5):641-8. doi: 10.1093/cid/cis942. Epub 2012 Nov 13.
The success of acinetobacter species; genetic, metabolic and virulence attributes.
Peleg AY, de Breij A, Adams MD, Cerqueira GM, Mocali S, Galardini M, Nibbering PH, Earl AM, Ward DV, Paterson DL, Seifert H, Dijkshoorn L.
PLoS One. 2012;7(10):e46984. doi: 10.1371/journal.pone.0046984. Epub 2012 Oct 29.
Toward improved surveillance: the impact of ventilator-associated complications on length of stay and antibiotic use in patients in intensive care units.
Hayashi Y, Morisawa K, Klompas M, Jones M, Bandeshe H, Boots R, Lipman J, Paterson DL.
Clin Infect Dis. 2013 Feb;56(4):471-7. doi: 10.1093/cid/cis926. Epub 2012 Nov 1.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on